Chinese SDA (State Drug Administration) gets EU regulatory update:
This article was originally published in Clinica
Executive Summary
The latest regulatory developments in the EU and China will be on the agenda when officials from the Chinese State Drug Administration visit the European device industry association, Eucomed, on September 19-20 2002. The Chinese delegation, led by SDA medical devices registration division director Chang Yongheng, will also meet DG Enterprise officials, UK notified body BSI and the MDA during their brief tour. The Chinese medial devices market is valued by the US Department of Commerce at $5.2bn, $1.4bn of which (in 2000) was provided by imports. Imports grew by 15.5% that year, says Eucomed.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.